Hydreight Technologies Inc (NURS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 181 | 108 | 37 | N/A | N/A |
| Accounts receivable | -54 | -19 | -5 | N/A | N/A |
| Accounts payable and accrued liabilities | 437 | 1,134 | 252 | 383 | -4 |
| Other Working Capital | 367 | 981 | 1,295 | 380 | 252 |
| Other Operating Activity | -74 | -2,608 | -1,909 | -910 | -227 |
| Operating Cash Flow | $857 | $-402 | $-330 | $-148 | $21 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -3 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,182 | -209 | -67 | -378 | 0 |
| Other Investing Activity | 4 | -91 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,178 | $-302 | $-67 | $-378 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 0 | -1 |
| Debt Repayment | 0 | -19 | -22 | N/A | N/A |
| Common Stock Issued | N/A | 0 | 355 | N/A | N/A |
| Common Stock Repurchased | -7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -56 | 50 | 2,484 | 500 | 0 |
| Financing Cash Flow | $-63 | $31 | $2,816 | $500 | $-1 |
| Exchange Rate Effect | -212 | 25 | 6 | 0 | 12 |
| Beginning Cash Position | 1,784 | 2,432 | 6 | 33 | 0 |
| End Cash Position | 1,187 | 1,784 | 2,432 | 6 | 33 |
| Net Cash Flow | $-385 | $-673 | $2,420 | $-26 | $20 |
| Free Cash Flow | |||||
| Operating Cash Flow | 857 | -402 | -330 | -148 | 21 |
| Capital Expenditure | -1,182 | -211 | -67 | -378 | N/A |
| Free Cash Flow | -326 | -614 | -396 | -527 | 21 |